Gene expression patterns of insulin-like growth factor 1, 2 (IGF-1, IGF-2) and insulin-like growth factor binding protein 3 (IGFBP-3) in human placenta from preterm deliveries: influence of additional factors

被引:17
|
作者
Demendi, Csaba [2 ]
Boerzsoenyi, Balazs [2 ]
Nagy, Zsolt B.
Rigo, Janos, Jr. [1 ]
Pajor, Attila [2 ]
Joo, Jozsef Gabor [1 ]
机构
[1] Semmelweis Univ, Dept Obstet & Gynecol 1, Budapest, Hungary
[2] Semmelweis Univ, Dept Obstet & Gynecol 2, Budapest, Hungary
关键词
Gene expression; Placenta; Insulin-like growth factor; Preterm delivery; Intrauterine infection; Smoking; FACTOR-I; GESTATIONAL-AGE; FETAL; RISK; BIRTH;
D O I
10.1016/j.ejogrb.2011.10.005
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To compare patterns of human placental gene expression of IGF from pregnancies that ended with preterm delivery vs. full term pregnancies as controls. Study design: Real-time PCR was used to assess gene expression of IGF in human placental samples from 104 preterm and 140 full term pregnancies. Results: In the preterm delivery group, the proportion of smokers was significantly higher than in the control group. A history of preterm delivery was more common in the preterm delivery group compared to the control group. In the preterm delivery group, placental samples showed an underexpression of the IGF-1 gene compared to controls. In cases of male fetal gender an overexpression of both the IGF-2 and the IGFBP-3 genes was observed. Conclusion: Among environmental factors influencing preterm delivery, smoking was the most significant in our study. In the majority of cases, preterm delivery was induced by intrauterine infection leading to a decreased activity of the IGF system. This mechanism may also play a role in the development of neurological sequelae and in decreased tolerance to fetal distress. The overexpression of the IGF-2 gene observed in the placenta with male fetal gender can be explained by its physiological role in the development of the male phenotype. (C) 2011 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:40 / 44
页数:5
相关论文
共 50 条
  • [1] Association of Insulin-like Growth Factor-1 (IGF-1) and Insulin-like Growth Factor Binding Protein-3 (IGFBP-3) with the Metabolic Syndrome
    Kong, Mi Hee a
    Joo, Nam Seok
    Kim, Kwang Min
    Kim, Bom Taeck
    Kim, Sang Man
    Lee, Duck Joo
    KOREAN JOURNAL OF FAMILY MEDICINE, 2007, 28 (02): : 127 - 133
  • [2] Usefullness of Serum Insulin-Like Growth Factor (IGF-1) and Insulin-Like Growth Factor Binding Protein-3 (IGFBP-3) for Colorectal Cancer Diagnosis
    Yilmazi, Oemer
    Koruk, Irfan
    Cayir, Kerim
    Koruk, Mehmet
    Yilmaz, Arif
    UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2009, 19 (01): : 23 - 27
  • [3] The relationship between maternal insulin-like growth factors 1 and 2 (IGF-1, IGF-2) and IGFBP-3 to gestational age and preterm delivery
    Cooley, Sharon M.
    Donnelly, Jennifer C.
    Collins, Claire
    Geary, Michael P.
    Rodeck, Charles H.
    Hindmarsh, Peter C.
    JOURNAL OF PERINATAL MEDICINE, 2010, 38 (03) : 255 - 259
  • [4] Gene expression patterns of insulin-like growth factor 1, insulin-like growth factor 2 and insulin-like growth factor binding protein 3 in human placenta from pregnancies with intrauterine growth restriction
    Boerzsoenyi, Balazs
    Demendi, Csaba
    Nagy, Zsolt
    Toth, Katalin
    Csanad, Monika
    Pajor, Attila
    Rigo, Janos, Jr.
    Joo, Jozsef Gabor
    JOURNAL OF PERINATAL MEDICINE, 2011, 39 (06) : 701 - 707
  • [5] Immunoassays for human insulin-like growth factor (IGF) binding protein-3 (IGFBP-3).
    Diamandis, A
    Mistry, J
    Khosravi, MJ
    CLINICAL CHEMISTRY, 1998, 44 : A147 - A147
  • [6] Antibodies against the receptor for insulin-like growth factor 1 (IGF-1RAb), insulin-like growth factor 1 (IGF-1), and insulin-like growth factor binding protein 3 (IGFBP-3) in the serum of patients with Graves' and Basedow's disease with and without orbitopathy
    Nowak, Mariusz
    Wielkoszynski, Tomasz
    Londzin-Olesik, Magdalena
    Nowak, Wojciech
    Marek, Bogdan
    Kos-Kudla, Beata
    Sieminska, Lucyna
    Glogowska-Szelag, Joanna
    Kajdaniuk, Dariusz
    Karpe, Jacek
    ENDOKRYNOLOGIA POLSKA, 2025, 76 (01) : 40 - 51
  • [7] ROLE OF INSULIN-LIKE GROWTH FACTOR 1 (IGF-1) AND INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN-3 (IGFBP-3) IN THE DIAGNOSIS OF PANCREATIC ADENOCARCINOMA AND MONITORING TREATMENT RESPONSE
    Bademler, Suleyman
    Ucuncu, Whammed Zubeyr
    Sari, Murat
    Yasasever, Ceren Tilgen
    Afsar, Cigdem Usul
    Tastekin, Didem
    ACTA MEDICA MEDITERRANEA, 2019, 35 (01): : 71 - 75
  • [8] Clinical significance of serum insulin-like growth factor-1 (IGF-1) and insulin-like growth factor binding protein-3 (IGFBP-3) in patients with breast cancer
    Tas, Faruk
    Karabulut, Senem
    Bilgin, Elif
    Tastekin, Didem
    Duranyildiz, Derya
    TUMOR BIOLOGY, 2014, 35 (09) : 9303 - 9309
  • [9] Growth hormon (GH), insulin-like growth factor (IGF-1) and insulin-like growth factor binding protein (IGFBP-3) in young diabetic patients with the onset of diabetic angiopathy
    Peczynska, J
    Urban, M
    Glowinska, B
    DIABETOLOGIA, 2002, 45 : A11 - A12
  • [10] CLINICAL SIGNIFICANCE OF SERUM INSULIN-LIKE GROWTH FACTOR-1 (IGF-1) AND INSULIN-LIKE GROWTH BINDING PROTEIN-3 (IGFBP-3) IN PATIENTS WITH GASTRIC CANCER
    Bademler, Suleyman
    Sari, Murat
    Ucuncu, Muhammet Zubeyr
    Serilmez, Murat
    Karabulut, Senem
    ACTA MEDICA MEDITERRANEA, 2018, 34 (06): : 2055 - 2060